Dec 17, 2025 04:27AM
Nov 11, 2025 04:01PM
Oct 29, 2025 05:18AM
Sep 22, 2025 01:26PM
Nov 5, 2024 04:01PM
Aug 19, 2024 05:37AM
May 29, 2024 04:01PM Neurocrine Biosciences to Participate at Investor Conferences in June
Apr 24, 2024 07:43AM
Nov 8, 2023 04:01PM
Aug 21, 2023 10:25AM
Mar 8, 2023 04:01PM
Nov 8, 2022 04:01PM
Jun 6, 2022 08:08AM
Nov 9, 2021 04:01PM Neurocrine Biosciences to Present at Upcoming Healthcare Conferences
Nov 9, 2020 09:00AM
Jun 8, 2020 04:13PM
May 26, 2020 04:01PM
Feb 5, 2020 09:34AM
Nov 5, 2019 04:01PM
May 30, 2019 04:01PM
Mar 21, 2019 03:43PM Biogen (BIIB) May Need More M&A Following AD Failure - Analysts
Dec 13, 2018 07:15AM
Dec 12, 2018 09:30AM
Nov 7, 2018 04:01PM
Nov 8, 2017 01:15PM
Oct 3, 2017 07:07AM
Jun 1, 2017 04:18PM
May 30, 2017 07:36AM Neurocrine Biosciences (NBIX): Survey Shows Ingrezza To Be Restricted - Jefferies
May 24, 2017 06:37AM
May 22, 2017 07:40AM
May 9, 2017 07:26AM
May 2, 2017 05:04PM
May 1, 2017 06:50AM
Apr 12, 2017 06:39AM
Apr 4, 2017 06:59AM Neurocrine Biosciences (NBIX): Austedo Approved, Ingrezza Next - Jefferies
Jan 18, 2017 06:41AM
Jan 6, 2017 09:29AM
Nov 10, 2016 01:00PM
Nov 8, 2016 07:14AM
Jun 2, 2016 03:45PM
May 23, 2016 07:12AM
May 18, 2016 07:53AM Neurocrine Bio's (NBIX) Valbenazine Data Better Than Teva's (TEVA)- Jefferies
Apr 14, 2016 07:58AM
Mar 28, 2016 08:33AM
Nov 11, 2015 02:10PM
Oct 19, 2015 08:28AM
Aug 18, 2015 06:43AM
May 27, 2015 03:54PM
Feb 19, 2015 07:04AM Neurocrine Biosciences (NBIX) Prices 6.9M Shares at $36/Share
Jan 20, 2015 07:54AM

72,063 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All